Evaluation of a Smartphone Application to Reduce Adverse Pregnancy Outcomes in Ethiopia
6. oktober 2015 opdateret af: Stine Lund, MD, PhD fellow, University of Copenhagen
Evaluation of a Smartphone Application to Reduce Adverse Pregnancy Outcomes in Ethiopia: A Cluster-randomised Controlled Trial
The purpose of this trial is to determine if the safe delivery smartphone application distributed to health workers in Ethiopia will decrease perinatal mortality and the incidence of postpartum haemorrhage.
It is also the purpose to determine if the safe delivery smartphone application distributed to health workers in Ethiopia will increase health workers knowledge and skills in intra-partum management of active management of third stage labour 2) treatment of post-partum haemorrhage 3) manual removal of placenta and 4) neonatal resuscitation.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Abstract Hypothesis A safe delivery smartphone application distributed to health workers in Ethiopia will decrease perinatal mortality and the incidence of postpartum haemorrhage
A safe delivery smartphone application distributed to health workers in Ethiopia will increase health workers knowledge and skills in intra-partum management of active management of third stage labour 2) treatment of post-partum haemorrhage 3) manual removal of placenta and 4) neonatal resuscitation
Intervention A safe delivery smartphone application with animated videos to improve clinical management during delivery will be introduced in the intervention clusters
Design Cluster randomized controlled trial with health facilities as the unit of randomization
Area Nole Kaba, Haru, Homa, Genji and Gimbie districts in Ethiopia
Population Pregnant women and their newborns delivered in a randomized health facility. For secondary outcomes health workers at randomized health facilities.
Sample size 77 health facilities with minimum 2 health workers per facility and 30 deliveries per health worker
Duration Pregnant women will be enrolled at delivery and followed to 7 days postpartum
Outcomes Primary outcomes are perinatal mortality and postpartum haemorrhage. Secondary outcomes are health workers knowledge and skills
Study time Data collection expected from September 2013 to September 2014
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
3601
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
København V, Danmark, 1658
- University of Copenhagen
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
10 år til 45 år (Barn, Voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Kvinde
Beskrivelse
Inclusion Criteria:
• Women in active labor
Exclusion Criteria:
• None
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Safe Delivery Smartphone Application
The safe delivery smartphone application is designed to train midwives and other birth attendants in developing countries in management of normal and complicated deliveries.
The safe delivery smartphone application will be introduced to health workers in the intervention clusters.
|
The safe delivery smartphone application is designed to train midwives and other birth attendants in developing countries in management of normal and complicated deliveries.
The application is furthermore intended as a reference tool that could be used during clinical work for example for preparation before attending a birth, in a situation when a complication occurs, or for debriefing and self-evaluation after a complication.
The application features four animated videos with clinical instructions of 3-8 minutes duration and written lists of essential obstetric drugs (indications, contraindications, dosage and administration and side effects) and essential equipment for a safe delivery.
|
|
Ingen indgriben: Control
Health workers in the control clusters will not have access to the Safe Delivery App
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Perinatal mortality (stillbirth and early neonatal death)
Tidsramme: Participants will be followed from delivery until 7 days postpartum
|
Participants will be followed from delivery until 7 days postpartum
|
|
Postpartum haemorrhage
Tidsramme: Participants will be followed from delivery until two hours postpartum
|
Participants will be followed from delivery until two hours postpartum
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Health workers clinical performance in active management of third stage of labour, postpartum haemorrhage and manual removal of placenta
Tidsramme: 0, 6 and 12 months
|
0, 6 and 12 months
|
|
Health workers clinical performance in management of neonatal resuscitation
Tidsramme: 0, 6 and 12 months
|
0, 6 and 12 months
|
|
Health workers knowledge of management of active management of third stage of labour, manual removal of placenta and postpartum haemorrhage
Tidsramme: 0, 6 and 12 months
|
0, 6 and 12 months
|
|
Health workers knowledge of management of neonatal resuscitation
Tidsramme: 0, 6 and 12 months
|
0, 6 and 12 months
|
Andre resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Mortality stratified according to gestational age and birth weight
Tidsramme: Participants will be followed from delivery until 7 days postpartum
|
Participants will be followed from delivery until 7 days postpartum
|
|
Use of the Safe Delivery application (when, how much and by whom)
Tidsramme: Participants will be followed during the 12 months trial period
|
Participants will be followed during the 12 months trial period
|
|
Process indicators of services provided
Tidsramme: Participants will be followed from delivery until 7 days postpartum
|
Participants will be followed from delivery until 7 days postpartum
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. september 2013
Primær færdiggørelse (Faktiske)
1. december 2014
Studieafslutning (Faktiske)
1. januar 2015
Datoer for studieregistrering
Først indsendt
5. september 2013
Først indsendt, der opfyldte QC-kriterier
16. september 2013
Først opslået (Skøn)
19. september 2013
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
8. oktober 2015
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
6. oktober 2015
Sidst verificeret
1. oktober 2015
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- SafeDeliveryApp
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Mødredødelighed
-
National Human Genome Research Institute (NHGRI)National Cancer Institute (NCI)Rekruttering
-
Forman Christian College, PakistanUNICEFRekrutteringModerens sundhed | Maternal Health LiteracyPakistan
-
University Hospital, Basel, SwitzerlandAfsluttetMaternal hæmodynamisk stabilitetSchweiz
-
University of Milano BicoccaAfsluttetEkstern Cephalic version | Maternal Oral HydrationItalien
-
Harvard School of Public Health (HSPH)Brigham and Women's HospitalAfsluttetGraviditetskomplikationer | Komplikationer ved kejsersnit | Maternal komplikation af graviditet | Kommunikation, TværfaglighedForenede Stater
-
Aga Khan UniversityThe Hospital for Sick Children; Bill and Melinda Gates FoundationAktiv, ikke rekrutterendeNyfødt sygelighed | Maternal komplikation af graviditet | Perinatale problemerPakistan
-
University of Alabama at BirminghamEunice Kennedy Shriver National Institute of Child Health and Human Development...RekrutteringMaternal Cytomegalovirus Infektioner | Cytomegalovirus medfødtForenede Stater
-
Medical University of ViennaAfsluttetMitokondrielt DNA | Epidural-relateret maternal feber (ERMF)Østrig
-
IVI MadridAfsluttetMaternal-Fetal KIR-HLA-C-kompatibilitet
-
Federal University of PelotasAfsluttetPræmaturitet | Svangerskabsforhøjet blodtryk | Maternal post-partum depression | Maternal post-partum vægtretention | Barnets udviklingBrasilien